Circulating exosomes may provide a more sensitive platform to monitor disease progression compared to circulating tumor cells.
Traci Pawlowski(Illumina (United States)), Christine Kuslich(Phoenix (United States)), Peter Ellis(Oldham Council), David Spetzler(Caris Life Sciences (United States)), Annemarie Tyrell, Tingming Deng, Teresa L. Tinder(Freeport-McMoRan (United States)), J. Kim, J. C. Kimbrough(Freeport-McMoRan (United States)), Patrick Kennedy(Queen Mary University of London)
Cited by 2
Related Papers
High burden and pervasive positive selection of somatic mutations in normal human skin
|Science|2015|1.8k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
The UK10K project identifies rare variants in health and disease
|Nature|2015|1.2k